A. J. Kazimi - 13 Jun 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
13 Jun 2024
Net transactions value
+$691
Form type
4
Filing time
02 Jul 2024, 17:31:28 UTC
Previous filing
26 Mar 2024
Next filing
02 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $38 +25 +0% $1.52 5,695,582 13 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $72 +48 +0% $1.50 5,695,630 14 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.09 +41 +0% $1.49 5,695,671 17 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $64.37 +41 +0% $1.57 5,695,712 18 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $62.73 +41 +0% $1.53 5,695,753 20 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.09 +41 +0% $1.49 5,695,794 21 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $69.96 +44 +0% $1.59 5,695,838 24 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $67.76 +44 +0% $1.54 5,695,882 25 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $66 +44 +0% $1.50 5,695,926 26 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $66.88 +44 +0% $1.52 5,695,970 27 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.5 +41 +0% $1.50 5,696,011 28 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.